Last updated: December 22, 2023
Sponsor: CIPLA
Overall Status: Active - Recruiting
Phase
3
Condition
Asthma
Treatment
N/AClinical Study ID
TX322057
CRD/58
Ages 18-65 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria
To be eligible, participants must be:
- 18-65 years of age
- Able to attend up to 7 office visits within approximately 11 weeks (each visit will take between 3 - 9 hours)
*Additional criteria may apply
Those who qualify will receive:
- Study-related exams, including pulmonary function testing
- Compensation for time and travel
- Dose in the office using inhalers containing study drug or placebo
Study Design
Study Start date:
October 02, 2023
Estimated Completion Date:
May 31, 2024
Study Description
Connect with a study center
North Carolina Clinical Research
Raleigh, NC 27607
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.